Kiromic Biopharma, Inc.
KRBPDelisted Nov 20, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001792581
Kiromic Biopharma, Inc. was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Aug 26, 2024; no institution reported holding it in 13F filings for Q3 2023; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 0
- Q3 2023, −5 vs. previous quarter
- 13F value
- $0
- Reported value at the end of Q3 2023
- Superinvestors holding
- 0
- At the end of Q3 2023
Superinvestors holding KRBP, Q3 2023
No superinvestor reported holding KRBP at the end of Q3 2023.
Latest insider trades
Open-market purchases and sales by Kiromic Biopharma, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 26, 2024 (view filing) | Aug 23-26 | 3 days | Bersani PietroChief Executive Officer | PPurchase | +3.49K | $2.12 | +$7.41K | +2.5%142.3K after | 2 lots |
| Aug 21, 2024 (view filing) | Aug 19-20 | 2 days | Hungerford BrianChief Financial Officer | PPurchase | +4.00K | $2.20 | +$8.81K | +6.6%64.9K after | 2 lots |
| Aug 14, 2024 (view filing) | Aug 13 | 1 day | Hungerford BrianChief Financial Officer | PPurchase | +2.00K | $1.75 | +$3.50K | +3.4%60.9K after | |
| Jun 13, 2024 (view filing) | Jun 12 | 1 day | Misajon PamelaDirector | PPurchase | +1.61K | $3.28 | +$5.29K | +5.9%28.8K after | 2 lots |
| Jun 13, 2024 (view filing) | Jun 13 | Same day | Hungerford BrianCFO | PPurchase | +1.00K | $2.60 | +$2.60K | +1.7%58.9K after | |
| Jun 12, 2024 (view filing) | Jun 11 | 1 day | Nagel MichaelDirector | PPurchase | +1.00K | $3.33 | +$3.33K | +2.4%43.3K after | |
| Jun 12, 2024 (view filing) | Jun 10 | 2 days | Misajon PamelaDirector | PPurchase | +1.70K | $2.93 | +$4.98K | +6.7%27.2K after | |
| Jun 12, 2024 (view filing) | Jun 12 | Same day | Hungerford BrianCFO | PPurchase | +1.00K | $3.18 | +$3.18K | +1.8%57.9K after | |
| Jun 12, 2024 (view filing) | Jun 11-12 | 1 day | Bersani PietroCEO | PPurchase | +6.00K | $3.26 | +$19.5K | +4.5%138.8K after | 2 lots |
| Jun 4, 2024 (view filing) | Jun 3 | 1 day | Ralston Shannon10% Owner | PPurchase | +800.0K | – | – | – | DerivativePrice outlier |
Top 10 13F holders, Q3 2023
The largest institutional positions in Kiromic Biopharma, Inc. at the end of Q3 2023; share changes are against Q2 2023.
No institution reported holding KRBP in 13F filings for Q3 2023.